Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.17, $0.06 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $425 million versus the consensus estimate of $456.83 million.

GUIDANCE:

Exelixis sees FY2024 revenue of $1.83-1.93 billion, versus the consensus of $1.91 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.